. home.aspx
EVENTS
Pharmacoepidemiology & Therapeutic Risk Management
PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT
August 26-30, 2020
36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is organized by International Society for Pharmacoepidemiology (ISPE) and will be held from Aug 26 - 30, 2020 at Estrel Berlin, Berlin, Germany.

Drug Metabolism
DRUG METABOLISM
July 12-17, 2020
Drug Metabolism focuses on predicting drug metabolism using P450 structural information and aims to address a wide range of other relevant themes. The conference program will comprise of a keynote lecture, four morning and three evening sessions and poster sessions and it will be a coherent fusion o...

Cancer Research and Pharmacology
CANCER RESEARCH AND PHARMACOLOGY
July 01-02, 2020
Cancer Research 2020 is an extraordinary event designed for International medical health professionals, Pharmacologists and oncologists to facilitate the dissemination and application of research findings related to Cancer. The Cancer Research Conference invites participants from all leading univers...

C-SUITE ON DECK

home.aspx
   

Q&A With Sangram Vajre, Co-Founder & Chief Evangelist At Terminus

January 09, 2020 / MEDIA 7
SHARESHARESHARE
Sangram Vajre, Co-Founder & Chief Evangelist at Terminus is also an author and host of the podcast FlipmyFunnel. He is one of the leading minds in B2B marketing.

MEDIA 7: What are you passionate about?
SANGRAM VAJRE:
Three things: Lead professionally. Grow personally. Love family.

M7: Terminus has been recognized as one of Georgia’s 40 fastest-growing companies by ACG Atlanta. What factors contribute to this pace?
SV: 
One of our core values is #OneTeam – which means we think and act as one team and know that if we treat our team right, they will treat our customers amazing. There are no great companies, only great people that make those companies.

"Marketers who say they are going to transform their organization without support from Sales and buy-in from management fail to see success."

M7: Terminus is the leader of the account-based movement. What according to you are the common mistakes marketers make with ABM?
SV:
 Marketers who say they are going to transform their organization without support from Sales and buy-in from management fail to see success. The marketers who make a few sales people wildly successful, join campaigns to help them win deals, win their hearts and minds.

M7: Could you tell us a little bit about your podcast Flipmyfunnel? How did that idea come about?
SV:
 I was already talking to customers and amazing people in the industry and every time I would walk away with the thought that wish I recorded that conversation. Well, I just started doing that which turned into a podcast series that has now over 500 episodes and continue to rate in the top 50 business podcast.

"Terminus can quickly get a sales rep alerted when their target account is on the website which helps them prioritize which target accounts they need to spend more time with."

M7: What are some of the best indicators that a prospect is really engaged with your brand?
SV:
Visit to your website and the frequency of it. There are technologies like Terminus that can quickly get a sales rep alerted when their target account is on the website which helps them prioritize which target accounts they need to spend more time with. This could become one of the most important indicators of early success for companies in 2020.


M7: What marketing channels do you use and which ones do you see as the most promising given your target customers?
SV:
It’s always the combination that works since everyone is different but the goal is to surround them with your message on their channels so when they are ready, they think of you.

"Mature and forward thinking CMOs are starting to help their sales team win more and faster by focusing on pipeline velocity and expansion deals."

M7: What aspects of ABM do you think might change in the future?
SV:
I believe ABM is B2B. Most companies are still focused on top of the funnel. Mature and forward thinking CMOs are starting to help their sales team win more and faster by focusing on pipeline velocity and expansion deals.


M7: What is your favorite quote?
SV:
Selling is essentially transfer of feelings – Zig Ziglar.


About Terminus


Terminus is the leader of the account-based movement and the crucial link that connects B2B marketing and sales teams with their ideal customers. The Terminus solution arms marketing teams with an account-centric platform that delivers the intelligence and automation needed to scale ABM and revolutionize the way B2B marketing is done. Hundreds of organizations worldwide, including Salesforce, GE, Verizon, 3M and CA Technologies, turn to Terminus to more effectively target, engage and grow their best-fit accounts. Terminus offers savvy marketers the technology and proven expertise to radically improve ABM strategies and campaigns, increasing ROI and producing exceptional results. For more information, visit Terminus.

SPOTLIGHT

Terminus is the leader of the account-based movement and the crucial link that connects B2B marketing and sales teams with their ideal customers. The Terminus solution arms marketing teams with an account-centric platform that delivers the intelligence and automation needed to scale ABM and revoluti

RELATED NEWS


AstraZeneca is back at it again with asset sales. The company, which has taken some flak for a series of deals to offload asset rights, inked an agreement with Luye Pharma for legacy antipsychotic Seroquel and an extended-release version.  The agreement covers Seroquel and Seroquel XR rights in the U.K., China and other markets such as Brazil, Australia, Saudi Arabia and Mexico. AstraZeneca will get $260 million when the deal closes expected by the end of the quarter plus up to $278 million...
FIERCEPHARMA
READ MORE

NICE has finalized its guidance recommending interim NHS funding for Gilead’s Yescarta CAR-T therapy, to treat patients with aggressive forms of non-Hodgkin lymphoma. A chimeric antigen-receptor T-cell (CAR-T) therapy, Yescarta (axicabtagene ciloleucel) is cleared for reimbursement through the Cancer Drugs Fund (CDF) following an agreement between Gilead’s Kite unit and NHS England. Gilead has managed to get Yescarta funded in this indication ahead of Novartis’ rival CAR-T, Kym...

READ MORE

Researchers from Case Western Reserve University School of Medicine and The Cleveland Clinic designed a way to screen brain tumor cells and identify potential drug targets missed by other methods. The team successfully used their technique to find a glioblastoma cancer gene that, when blocked, extends mouse survival rates. In a study published in Nature, the team implanted patient-derived glioblastoma cells in mice and measured gene activity in the growing brain tumors. They compared the gene ac...

READ MORE

China has updated list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world's second-largest drug market where many new drugs have been kept out of patients' reach because of high costs....

READ MORE

The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the almost 60-year-old Pharmaceutical Price Regulation Scheme (PPRS). The new Voluntary Scheme for Branded Medicines Pricing and Access has been agreed in principle with the Association of the British Pharmaceutical Industry (ABPI) but still needs the details to be teased out before it can be fully agreed and come into effect from 1 January 2019, after the current PPRS expires. The headline n...

READ MORE

Pharmaceutical giant Novartis International is scooping up Fort Worth-based Encore Vision as it aims to introduce the market’s first topical treatment of the eye condition presbyopia....
DMAGAZINE.COM
READ MORE

SPOTLIGHT

Terminus is the leader of the account-based movement and the crucial link that connects B2B marketing and sales teams with their ideal customers. The Terminus solution arms marketing teams with an account-centric platform that delivers the intelligence and automation needed to scale ABM and revoluti

RESOURCES

EVENTS

Pharmacoepidemiology & Therapeutic Risk Management
PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT
August 26-30, 2020
36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is organized by International Society for Pharmacoepidemiology (ISPE) and will be held from Aug 26 - 30, 2020 at Estrel Berlin, Berlin, Germany.

Drug Metabolism
DRUG METABOLISM
July 12-17, 2020
Drug Metabolism focuses on predicting drug metabolism using P450 structural information and aims to address a wide range of other relevant themes. The conference program will comprise of a keynote lecture, four morning and three evening sessions and poster sessions and it will be a coherent fusion o...

Cancer Research and Pharmacology
CANCER RESEARCH AND PHARMACOLOGY
July 01-02, 2020
Cancer Research 2020 is an extraordinary event designed for International medical health professionals, Pharmacologists and oncologists to facilitate the dissemination and application of research findings related to Cancer. The Cancer Research Conference invites participants from all leading univers...